Osa Surgery denied as duplicate or overlapping therapy by Humana?
If two medications appear duplicative on paper but serve different clinical purposes (e.g., short-acting vs long-acting), the appeal needs to spell out the clinical rationale for both.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Humana typically requires
Humana's specific coverage criteria for osa surgery are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Humana angle on Osa Surgery
## Why Humana Denied OSA Surgery as Duplicate Therapy
Humana may issue a duplicate-therapy denial for obstructive sleep apnea (OSA) surgery when your records show you are currently using or have recently been prescribed another active OSA treatment — most commonly continuous positive airway pressure (CPAP), bilevel PAP, or an oral appliance. The insurer's position is that surgery and the existing device-based therapy address the same condition and therefore cannot both be covered simultaneously. This reasoning frequently fails to account for the clinical reality that device-based therapy and surgical intervention are not equivalent options for all patients, and that surgery may be indicated specifically because non-surgical therapy has failed or is not tolerated.
## Why This Denial Is Appealable
A duplicate-therapy denial requires Humana to demonstrate that the surgical option is genuinely equivalent to, and not an appropriate next step beyond, the existing therapy. For OSA surgery, established clinical guidelines recognize surgery as an option for patients who cannot tolerate or have not responded adequately to non-surgical first-line therapies. If your prescriber has documented CPAP intolerance, non-adherence due to medical reasons, or inadequate response, the duplicate-therapy rationale collapses. Under ERISA §503 and ACA §2719, this is a reviewable adverse benefit determination.
## Federal Appeal Framework
- Internal appeal: File within 180 days of the denial notice. Humana must decide within 30 days for pre-service denials or 60 days for post-service claims.
- External review (ACA §2719): After exhausting internal appeals (or if Humana misses its decision deadline), you may request independent external review by a specialist. The external reviewer's decision is binding. The window is generally 4 months from the final internal adverse determination.
- Expedited review: If the OSA is severe and the delay poses a significant health risk (e.g., documented cardiovascular complications, severe hypoxemia), request expedited processing at both levels.
## Documentation to Gather
1. Diagnosis confirmation — polysomnography or home sleep study results confirming OSA diagnosis and severity classification. 2. Prior non-surgical treatment history — CPAP/bilevel PAP adherence data downloads (if available), dated records of trials, documented reasons for failure or intolerance (mask intolerance, claustrophobia, pressure intolerance, documented non-adherence with clinical explanation). 3. Oral appliance or positional therapy history — if applicable, documentation of prior trials with outcomes. 4. Clinical severity documentation — chart notes documenting OSA-related comorbidities, symptoms, and functional impairment. 5. Prescriber/surgeon medical-necessity letter — should explicitly address why surgery is not duplicative of the existing therapy, citing the specific reasons the existing treatment is inadequate for this patient. 6. Applicable guideline support — reference the relevant sleep medicine professional society's guidelines (e.g., American Academy of Sleep Medicine) for surgical candidacy criteria, generically.
## Criteria-Mapping Structure
Obtain Humana's published coverage policy for OSA surgical procedures. Copy each criterion into a table. For each requirement, cite the specific chart entry that satisfies it. The key issue in a duplicate-therapy appeal is demonstrating that non-surgical therapy was genuinely tried and found inadequate — map each piece of CPAP or device therapy history to the relevant policy criterion, and have your surgeon attest to the clinical rationale for proceeding to surgery.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →